Abstract

The development of dendrimers as potential drug carriers or scaffolds is currently one of the most active areas of pharmaceutical and biomedical sciences. Peptide dendrimers, an alternative class of dendrimers, are wedge-like molecules of high molecular weight, composed of basic amino acids associated through amide and peptide bonds; these bonds are present both inside the branching core and on their external surface. Delivery of drugs through skin has many advantages compared to the traditional routes (ie, reduced adverse effects, noninvasiveness and resulting patient compliance, avoidance of first-pass metabolism, and allowing for sustained drug delivery). Unlike acrylate dendrimers, peptide dendrimers are broken down to simple and harmless amino acids, possess low toxicity, and are cost-effective to prepare and purify in bulk when synthesized using solid-phase peptide synthesis. Hence, amino acid–based peptide dendrimers are being regarded as highly favorable scaffolds for the efficient and safe delivery of drugs or genes. In this regard, their future in the transdermal delivery of therapeutics is certainly necessary.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.